HIV Clinical Trials Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
HIV clinical trials help researchers find better ways to prevent, detect, or treat HIV. Examples of HIVclinical trials underway include studies of new HIV medicines, studies of vaccines to prevent or treat HIV, and studies of medicines to treat infections related to HIV.
This report aims to provide a comprehensive presentation of the global market for HIV Clinical Trials study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global HIV Clinical Trials Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global HIV Clinical Trials market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Phase I Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of HIV Clinical Trials include PPD Inc., IQVIA Inc., Parexel International Corporation, ICON plc, Syneos Health, WuXi AppTec, Janssen Global Services, LLC, Gilead Sciences, Inc. and Bionor Holding AS, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the HIV Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global HIV Clinical Trials Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global HIV Clinical Trials Market Segment Percentages, by Type, 2021 (%)
Phase I
Phase II
Phase III
Phase IV
Global HIV Clinical Trials Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global HIV Clinical Trials Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical & Biopharmaceutical Companies
Non Profit Organizations
Others
Global HIV Clinical Trials Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global HIV Clinical Trials Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HIV Clinical Trials revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies HIV Clinical Trials revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
PPD Inc.
IQVIA Inc.
Parexel International Corporation
ICON plc
Syneos Health
WuXi AppTec
Janssen Global Services, LLC
Gilead Sciences, Inc.
Bionor Holding AS
Charles River Laboratories
GSK plc.
SGS SA
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 HIV Clinical Trials Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global HIV Clinical Trials Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global HIV Clinical Trials Overall Market Size
2.1 Global HIV Clinical Trials Market Size: 2021 VS 2028
2.2 Global HIV Clinical Trials Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top HIV Clinical Trials Players in Global Market
3.2 Top Global HIV Clinical Trials Companies Ranked by Revenue
3.3 Global HIV Clinical Trials Revenue by Companies
3.4 Top 3 and Top 5 HIV Clinical Trials Companies in Global Market, by Revenue in 2021
3.5 Global Companies HIV Clinical Trials Product Type
3.6 Tier 1, Tier 2 and Tier 3 HIV Clinical Trials Players in Global Market
3.6.1 List of Global Tier 1 HIV Clinical Trials Companies
3.6.2 List of Global Tier 2 and Tier 3 HIV Clinical Trials Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global HIV Clinical Trials Market Size Markets, 2021 & 2028
4.1.2 Phase I
4.1.3 Phase II
4.1.4 Phase III
4.1.5 Phase IV
4.2 By Type - Global HIV Clinical Trials Revenue & Forecasts
4.2.1 By Type - Global HIV Clinical Trials Revenue, 2017-2022
4.2.2 By Type - Global HIV Clinical Trials Revenue, 2023-2028
4.2.3 By Type - Global HIV Clinical Trials Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global HIV Clinical Trials Market Size, 2021 & 2028
5.1.2 Pharmaceutical & Biopharmaceutical Companies
5.1.3 Non Profit Organizations
5.1.4 Others
5.2 By Application - Global HIV Clinical Trials Revenue & Forecasts
5.2.1 By Application - Global HIV Clinical Trials Revenue, 2017-2022
5.2.2 By Application - Global HIV Clinical Trials Revenue, 2023-2028
5.2.3 By Application - Global HIV Clinical Trials Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global HIV Clinical Trials Market Size, 2021 & 2028
6.2 By Region - Global HIV Clinical Trials Revenue & Forecasts
6.2.1 By Region - Global HIV Clinical Trials Revenue, 2017-2022
6.2.2 By Region - Global HIV Clinical Trials Revenue, 2023-2028
6.2.3 By Region - Global HIV Clinical Trials Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America HIV Clinical Trials Revenue, 2017-2028
6.3.2 US HIV Clinical Trials Market Size, 2017-2028
6.3.3 Canada HIV Clinical Trials Market Size, 2017-2028
6.3.4 Mexico HIV Clinical Trials Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe HIV Clinical Trials Revenue, 2017-2028
6.4.2 Germany HIV Clinical Trials Market Size, 2017-2028
6.4.3 France HIV Clinical Trials Market Size, 2017-2028
6.4.4 U.K. HIV Clinical Trials Market Size, 2017-2028
6.4.5 Italy HIV Clinical Trials Market Size, 2017-2028
6.4.6 Russia HIV Clinical Trials Market Size, 2017-2028
6.4.7 Nordic Countries HIV Clinical Trials Market Size, 2017-2028
6.4.8 Benelux HIV Clinical Trials Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia HIV Clinical Trials Revenue, 2017-2028
6.5.2 China HIV Clinical Trials Market Size, 2017-2028
6.5.3 Japan HIV Clinical Trials Market Size, 2017-2028
6.5.4 South Korea HIV Clinical Trials Market Size, 2017-2028
6.5.5 Southeast Asia HIV Clinical Trials Market Size, 2017-2028
6.5.6 India HIV Clinical Trials Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America HIV Clinical Trials Revenue, 2017-2028
6.6.2 Brazil HIV Clinical Trials Market Size, 2017-2028
6.6.3 Argentina HIV Clinical Trials Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa HIV Clinical Trials Revenue, 2017-2028
6.7.2 Turkey HIV Clinical Trials Market Size, 2017-2028
6.7.3 Israel HIV Clinical Trials Market Size, 2017-2028
6.7.4 Saudi Arabia HIV Clinical Trials Market Size, 2017-2028
6.7.5 UAE HIV Clinical Trials Market Size, 2017-2028
7 Players Profiles
7.1 PPD Inc.
7.1.1 PPD Inc. Corporate Summary
7.1.2 PPD Inc. Business Overview
7.1.3 PPD Inc. HIV Clinical Trials Major Product Offerings
7.1.4 PPD Inc. HIV Clinical Trials Revenue in Global Market (2017-2022)
7.1.5 PPD Inc. Key News
7.2 IQVIA Inc.
7.2.1 IQVIA Inc. Corporate Summary
7.2.2 IQVIA Inc. Business Overview
7.2.3 IQVIA Inc. HIV Clinical Trials Major Product Offerings
7.2.4 IQVIA Inc. HIV Clinical Trials Revenue in Global Market (2017-2022)
7.2.5 IQVIA Inc. Key News
7.3 Parexel International Corporation
7.3.1 Parexel International Corporation Corporate Summary
7.3.2 Parexel International Corporation Business Overview
7.3.3 Parexel International Corporation HIV Clinical Trials Major Product Offerings
7.3.4 Parexel International Corporation HIV Clinical Trials Revenue in Global Market (2017-2022)
7.3.5 Parexel International Corporation Key News
7.4 ICON plc
7.4.1 ICON plc Corporate Summary
7.4.2 ICON plc Business Overview
7.4.3 ICON plc HIV Clinical Trials Major Product Offerings
7.4.4 ICON plc HIV Clinical Trials Revenue in Global Market (2017-2022)
7.4.5 ICON plc Key News
7.5 Syneos Health
7.5.1 Syneos Health Corporate Summary
7.5.2 Syneos Health Business Overview
7.5.3 Syneos Health HIV Clinical Trials Major Product Offerings
7.5.4 Syneos Health HIV Clinical Trials Revenue in Global Market (2017-2022)
7.5.5 Syneos Health Key News
7.6 WuXi AppTec
7.6.1 WuXi AppTec Corporate Summary
7.6.2 WuXi AppTec Business Overview
7.6.3 WuXi AppTec HIV Clinical Trials Major Product Offerings
7.6.4 WuXi AppTec HIV Clinical Trials Revenue in Global Market (2017-2022)
7.6.5 WuXi AppTec Key News
7.7 Janssen Global Services, LLC
7.7.1 Janssen Global Services, LLC Corporate Summary
7.7.2 Janssen Global Services, LLC Business Overview
7.7.3 Janssen Global Services, LLC HIV Clinical Trials Major Product Offerings
7.7.4 Janssen Global Services, LLC HIV Clinical Trials Revenue in Global Market (2017-2022)
7.7.5 Janssen Global Services, LLC Key News
7.8 Gilead Sciences, Inc.
7.8.1 Gilead Sciences, Inc. Corporate Summary
7.8.2 Gilead Sciences, Inc. Business Overview
7.8.3 Gilead Sciences, Inc. HIV Clinical Trials Major Product Offerings
7.8.4 Gilead Sciences, Inc. HIV Clinical Trials Revenue in Global Market (2017-2022)
7.8.5 Gilead Sciences, Inc. Key News
7.9 Bionor Holding AS
7.9.1 Bionor Holding AS Corporate Summary
7.9.2 Bionor Holding AS Business Overview
7.9.3 Bionor Holding AS HIV Clinical Trials Major Product Offerings
7.9.4 Bionor Holding AS HIV Clinical Trials Revenue in Global Market (2017-2022)
7.9.5 Bionor Holding AS Key News
7.10 Charles River Laboratories
7.10.1 Charles River Laboratories Corporate Summary
7.10.2 Charles River Laboratories Business Overview
7.10.3 Charles River Laboratories HIV Clinical Trials Major Product Offerings
7.10.4 Charles River Laboratories HIV Clinical Trials Revenue in Global Market (2017-2022)
7.10.5 Charles River Laboratories Key News
7.11 GSK plc.
7.11.1 GSK plc. Corporate Summary
7.11.2 GSK plc. Business Overview
7.11.3 GSK plc. HIV Clinical Trials Major Product Offerings
7.11.4 GSK plc. HIV Clinical Trials Revenue in Global Market (2017-2022)
7.11.5 GSK plc. Key News
7.12 SGS SA
7.12.1 SGS SA Corporate Summary
7.12.2 SGS SA Business Overview
7.12.3 SGS SA HIV Clinical Trials Major Product Offerings
7.12.4 SGS SA HIV Clinical Trials Revenue in Global Market (2017-2022)
7.12.5 SGS SA Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
HIV Clinical Trials Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|